Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma
Lakshmi PK,
No information about this author
Rajesh Singh Pawar,
No information about this author
Yogesh Kumar Katare
No information about this author
et al.
ACS Pharmacology & Translational Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Diseases
of
multifactorial
origin
like
neurodegenerative
and
autoimmune
diseases
require
a
multitargeted
approach.
The
discovery
the
role
autoimmunity
in
glaucoma
retinal
ganglionic
cell
(RGC)
death
has
led
to
paradigm
shift
our
understanding
etiopathology
glaucoma.
Glaucoma
can
cause
irreversible
vision
loss
that
affects
up
an
estimated
3%
population
over
40
years
age.
current
pharmacotherapy
primarily
aims
manage
only
intraocular
pressure
(IOP),
modifiable
risk
factor
glaucomatous
neurodegeneration
RGCs.
However,
continues
happen
normotensive
patients
(where
IOP
is
below
reference
value),
silent
nature
disease
significant
visual
impairment
take
massive
toll
on
healthcare
system.
Cannabinoids,
although
known
reduce
since
1970s,
have
received
renewed
interest
due
their
neuroprotective,
anti-inflammatory,
immunosuppressive
effects
autoimmunity.
Additionally,
gut-retina
axis
abnormal
Wnt
signaling
makes
cannabinoids
even
more
relevant
because
action
multiple
targets,
all
converging
pathogenesis
neurodegeneration.
Cannabinoids
also
epigenetic
changes
immune
cells
associated
with
In
this
Review,
we
are
proposing
use
as
approach
for
treating
neurodegeneration,
especially
patients.
Language: Английский
The role of transcytosis in the blood-retina barrier: from pathophysiological functions to drug delivery
Chunlin Zhang,
No information about this author
Jing-Jie Ma,
No information about this author
Xiang Li
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
The
blood-retina
barrier
(BRB)
serves
as
a
critical
interface
that
separates
the
retina
from
circulatory
system,
playing
an
essential
role
in
preserving
homeostasis
of
microenvironment
within
retina.
Specialized
tight
junctions
and
limited
vesicle
trafficking
restrict
paracellular
transcellular
transport,
respectively,
thereby
maintaining
BRB
properties.
Additionally,
transcytosis
macromolecules
through
retinal
vascular
endothelial
cells
constitutes
primary
mechanism
for
transporting
substances
compartment
into
surrounding
tissue.
This
review
summarizes
fundamental
aspects
including
its
function
healthy
retina,
biochemical
properties
transcytosis,
methodologies
used
to
study
this
process.
Furthermore,
we
discuss
current
understanding
context
pathological
breakdown
present
recent
findings
highlight
significant
advances
drug
delivery
based
on
transcytosis.
Language: Английский
Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Since
the
trabecular
meshwork
(TM)
is
central
to
intraocular
pressure
(IOP)
regulation
and
glaucoma,
a
deeper
understanding
of
its
genomic
landscape
needed.
We
present
multimodal,
single-cell
resolution
analysis
mouse
limbal
cells
(includes
TM).
In
total,
we
sequenced
9,394
wild-type
TM
cell
transcriptomes.
discovered
three
subtypes
with
characteristic
signature
genes
validated
by
immunofluorescence
on
tissue
sections
whole-mounts.
The
are
robust,
being
detected
in
datasets
for
two
diverse
strains
independent
data
from
institutions.
Results
show
compartmentalized
enrichment
critical
pathways
specific
subtypes.
Distinctive
signatures
include
increased
expression
responsible
1)
extracellular
matrix
structure
metabolism
(TM1
subtype),
2)
secreted
ligand
signaling
support
Schlemm's
canal
(TM2),
3)
contractile
mitochondrial/metabolic
activity
(TM3).
ATAC-sequencing
identified
active
transcription
factors
cells,
including
LMX1B.
Mutations
LMX1B
cause
high
IOP
glaucoma.
emerging
as
key
factor
normal
mitochondrial
function
much
higher
TM3
than
other
cells.
To
understand
role
Lmx1b
V265D/+
mutant
mice.
mice,
were
uniquely
affected
pronounced
pathway
changes.
This
supports
primary
dysfunction
within
initiating
elevation
that
causes
glaucoma
these
Importantly,
treatment
vitamin
B
3
(nicotinamide),
enhance
metabolic
resilience,
significantly
protected
mice
elevation.
Language: Английский
Stress-induced mitochondrial fragmentation in endothelial cells disrupts blood-retinal barrier integrity causing neurodegeneration.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 22, 2024
Increased
vascular
leakage
and
endothelial
cell
(EC)
dysfunction
are
major
features
of
neurodegenerative
diseases.
Here,
we
investigated
the
mechanisms
leading
to
EC
dysregulation
asked
whether
altered
mitochondrial
dynamics
in
ECs
impinge
on
barrier
integrity
neurodegeneration.
We
show
that
ocular
hypertension,
a
risk
factor
develop
glaucoma,
induced
fragmentation
retinal
capillary
accompanied
by
increased
oxidative
stress
ultrastructural
defects.
Analysis
components
revealed
overactivation
dynamin-related
protein
1
(DRP1),
central
regulator
fission,
during
glaucomatous
damage.
Pharmacological
inhibition
or
EC-specific
vivo
gene
delivery
dominant
negative
DRP1
mutant
was
sufficient
rescue
volume,
reduce
leakage,
increase
expression
tight
junction
claudin-5
(CLDN5).
further
demonstrate
EC-targeted
CLDN5
augmentation
restored
blood-retinal-barrier
integrity,
promoted
neuronal
survival,
improved
light-evoked
visual
behaviors
mice.
Our
findings
reveal
preserving
homeostasis
function
valuable
strategies
enhance
neuroprotection
improve
vision
glaucoma.
Language: Английский